Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Free Cash Flow: 2018-2024

Historic Free Cash Flow for Therapeutics (RAPT) over the last 7 years, with Dec 2024 value amounting to -$83.4 million.

  • Therapeutics' Free Cash Flow rose 62.47% to -$10.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$83.4 million, marking a year-over-year increase of 15.03%. This contributed to the annual value of -$83.4 million for FY2024, which is 15.03% up from last year.
  • According to the latest figures from FY2024, Therapeutics' Free Cash Flow is -$83.4 million, which was up 15.03% from -$98.2 million recorded in FY2023.
  • In the past 5 years, Therapeutics' Free Cash Flow ranged from a high of -$40.9 million in FY2020 and a low of -$98.2 million during FY2023.
  • Over the past 3 years, Therapeutics' median Free Cash Flow value was -$83.4 million (recorded in 2024), while the average stood at -$84.4 million.
  • Per our database at Business Quant, Therapeutics' Free Cash Flow plummeted by 51.09% in 2021 and then grew by 15.03% in 2024.
  • Therapeutics' Free Cash Flow (Yearly) stood at -$40.9 million in 2020, then plummeted by 51.09% to -$61.8 million in 2021, then dropped by 15.92% to -$71.6 million in 2022, then slumped by 37.08% to -$98.2 million in 2023, then grew by 15.03% to -$83.4 million in 2024.